Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient

Area of Science:

• Neuroimmunology
• Nephrology
• Infectious Diseases

Background:

• Renal transplantation requires immunosuppressive therapy to prevent organ rejection.
• Immunosuppression can increase the risk of opportunistic infections, including viral encephalitis.
• Progressive multifocal leukoencephalopathy (PML) is a rare, demyelinating disease of the central nervous system.

Observation:

• A 47-year-old male renal transplant recipient developed focal seizures and cognitive decline 5 months post-transplantation.
• Brain biopsy confirmed findings consistent with progressive multifocal leukoencephalopathy (PML).
• The patient exhibited enhancing lesions in the parietal lobe.

Findings:

• Discontinuation of immunosuppressive therapy resulted in gradual neurological symptom resolution over 4 weeks.
• Follow-up imaging 36 months post-diagnosis showed complete resolution of PML lesions.
• The patient returned to hemodialysis 3 months after stopping immunosuppression.

Implications:

• Early recognition and management of PML in renal transplant recipients are crucial.
• Reversal of immunosuppression can lead to favorable outcomes in PML cases.
• This case underscores the importance of monitoring for opportunistic infections post-transplantation.